Neisseria gonorrhoeae, Culture
15q Deletion, Type I and Type II Characterization, Prader-Willi/Angelman Syndromes, FISH
Alprazolam, Serum
Insulin-Like Growth Factor Binding Protein 3 (IGFBP-3)
ClonoSeq Assay
Vitamin E
SARS-CoV-2 (COVID-19) Coronavirus, Genotyping
Biopsy, Frozen Section
Beta-Thalassemia
Tobramycin, Trough, Serum

LDS
Sign up
Log in

LDS
/Medical Tests
/CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)

All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References

All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Clinical Utility

Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.